The Effect of SGLT2 Inhibition on Urinary Adenosine Excretion in Patients with Type 1 Diabetes
Harindra Rajasekeran(University of Toronto), David Cherney, Heather Reichvathany Kulasingam, Yuliya Lytvyn(University Health Network), Daniel Cattran(University of Toronto), Bruce A. Perkins(Sinai Health System), Andrea Božović(University Health Network), Michelle Hladunewich(Sunnybrook Health Science Centre)
Cited by 4
Related Papers
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group
|Kidney International|2017|1.2k
The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility
|Kidney International|2009|1k
Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy
|JAMA|2017|540
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure
|Circulation|2017|470